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缩写词                    原文                    中文释义 
CD                  cytosine deaminase           胞嘧啶脱氨酶  
TK                  thymidine kinase             胸苷激酶 
CEA                 carcinoembryonic antige       癌胚抗原 
Cp                  CEA promoter               癌胚抗原启动子 
CRC                colcrecatal cancer             大肠癌 
GCV                ganciclovir                  更昔洛韦 
5-FC                5-fluorocytosine              5-氟胞嘧啶 
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都有 CEA 过度表达，因此已有相关的体外研究结果显示了由 CEA 启动子驱动的 CD-TK
双自杀基因能达到靶向杀伤大肠癌细胞的目的，从而提高了自杀基因治疗的效果，但在
体内的治疗结果如何却尚未见相关方面的研究。据此我们设计了本实验，期望通过体内




构建由 CEA 驱动的靶向性基因治疗载体 pcDNA3.1(-)Cp-CD-TK，通过裸鼠体内实




1. 构建靶向性基因治疗载体 pcDNA3.1(-)Cp-CD-TK。 
















3. 将脂质体介导的 pcDNA3.1(-)Cp-CD-TK 以瘤体内注射的方法分别转染人大肠 
癌 SW480 细胞和 Hela 细胞。 






1. 正确构建靶向性基因治疗载体 pcDNA3.1(-)Cp-CD-TK。 
2. 转染了靶向性载体 pcDNA3.1(-)Cp-CD-TK 的 SW480 细胞经过 RT-PCR 鉴定证
实有 CD-TK 基因的表达，CEA 阴性 Hela 细胞则没有 CD-TK 基因的表达。 
3. 在裸鼠体内前药 5-FC 和 GCV 能通过 pcDNA3.1(-)Cp-CD-TK 载体对 CEA 阳性
的人大肠癌产生抑瘤作用，而对 CEA 阴性人宫颈癌无作用。 
4. 双自杀基因治疗比单自杀基因治疗能产生更好的抑瘤效果。 
结论 
CEA 启动子驱动的 CD-TK 在体内能靶向作用于 CEA 阳性的人大肠癌细胞，并通
过前体药物治疗产生显著的抑瘤作用，且双自杀基因治疗的效果优于单自杀基因治疗。 
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Study on the targeted therapy for colorectal cancer in vivo  
with CD-TK driven by CEA promoter 
Abstract 
Background: 
   Colorectal cancer is one of the most common malignant tumor which severely threaten 
the human’s health. Present in our large cities it’s incidence rate in malignant tumor has 
become the third place. While with the early detection of disease, improved surgical program 
and the application of new chemotherapy drugs, the median survival time of patients has 
been greatly improved over the previous, but to achieve long-term disease-free survival is 
still a very big problem. Therefore, the search for new effective treatments become urgent 
issues. With the molecular biology and genetic engineering technology continues to evolve, 
tumor suicide gene therapy become the research focus. Currently, CD-TK double suicide 
gene-related research reports in the preliminary show better anti-tumor efficacy, and the key 
factor in suicide gene therapy is a highly efficient transfer vector and the targeting of high 
transcriptional promoter activity driven by gene. In view of the great majority of colorectal 
cancer are CEA over-expression, therefore, in vitro studies have shown related by the CEA 
promoter-driven CD-TK double suicide gene to achieve the purpose of targeting 
anti-colorectal cancer, and to improve the effectiveness of suicide gene therapy. Since few in 
vivo studies reported, we have designed this experiment, hope that, through in vivo 
experiments confirmed that the CEA-driven CD-TK double suicide gene (pcDNA3.1 (-) 
Cp-CD-TK) to achieve the purpose of targeting therapy of colorectal cancer, and the effect of 
double suicide gene therapy is better than the single suicide gene therapy, so as to find a new 
way of colorectal cancer treatment and do something meaningful exploration. 
Objective: 
To construct targeted plasmid vector pcDNA3.1(-)Cp-CD-TK which contains CEA 















double suicide gene can targeted express in CEA-positive colorectal cancer cells. To 
observe that if the gene can effectively kill the CEA-positive colorectal cancer cells in vivo 
after pro-drug therapy, and to compare the effect of the double suicide gene therapy and the 
single suicide gene therapy. 
Methods: 
1. To constructed the targeted plasmid vector pcDNA3.1(-)Cp-CD-TK. 
2. The CEA-positive colorectal cancer SW480 cells and CEA-negative Hela cells were 
inoculated into nude mice respectively, and create different groups of nude mice. 
3. The liposome-mediated pcDNA3.1 (-) Cp-CD-TK were respectively transfected into 
human colorectal cancerSW480 cells and Hela cells by the way of intratumoral injection. 
4. RT-PCR were used to detect CD-TK double suicide gene in tumor-bearing nude mice 
model in different expression 
5. Different groups of nude mice were given different drugs, and to observed the different 
treatment responses by calculating the tumor volume. 
6. Observed the morphological changes of tumor cells under the microscope 
7. Using the statistical method to test whether the differences in different groups was 
statistically significant 
Results 
1. The targeted plasmid vector pcDNA3.1(-)Cp-CD-TK was constructed successfully. 
2. By the way of RT-PCR ,it confirmed that CD-TK gene was expressed in CEA-positive 
colorectal cancer SW480 cells ,but not in CEA-negative Hela cells. 
3. In nude mice, the pro-drug 5-FC and GCV through pcDNA3.1 (-)p-CD-TK vector 
generated CEA-positive colorectal cancer inhibitory effect, while no effect on CEA-negative 
human cervical cancer. 
4. Double suicide gene therapy can produce better anti-tumor effect than single suicide gene 
therapy. 
Conclusions: 















colorectal cancer cells in vivo, through pro-drug therapy it can produce a significant 
inhibitory effect, and double suicide gene therapy is better than the single suicide gene 
therapy. 
Key Words: 
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距甚远的两个肿瘤也可以发生旁观者效应, 即一个表达了 TK 基因的肿瘤受 GCV 处理
而萎缩时，另一未被转染表达 TK 基因的肿瘤也同样萎缩, 称之为远程旁观者效应【4】。
目前已经发现和克隆的自杀基因有多种，而在大肠癌的自杀基因治疗中运用 广泛的为
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异性地将核苷类似物无环鸟苷(ACV) 或丙氧鸟苷( GCV) 单磷酸化，进而在肿瘤细胞内




动物细胞内不含该酶。该酶的功能是可将抗真菌药物 5-氟胞嘧啶(5-fluorocytosine ,5-FC) 
转变为抗肿瘤药物 5-氟尿嘧啶(5-fluorouracil , 5-FU) 【6】。5-FU 代谢生成 5FdUMP , 













将 AFP 基因作为增强子装入磷酸化激酶（pgk）启动子调控的 HSV-TK 基因中, 以逆转
录病毒为载体分别转染肝癌细胞系和非肝癌细胞系, 结果，肝癌细胞系中， AFP-TK 转
染组较未含 AFP 组对前体药物 GCV 具有更强的敏感性；而非肝癌细胞中，AFP-TK 转
染组对 GCV 却具有明显的耐药性, 提示 AFP 增强子能显著增强 HSV-TK 基因表达的肝
癌细胞特异性。由于 70％-90％以上的大肠癌细胞均有表达癌胚抗原（CEA）【10】, 因此
利用 CEA 作为启动子转导自杀基因可达到靶向表达于大肠癌细胞的目的。吴文溪等【11】
建立 CEA 启动子驱动的含 CD 基因的腺病毒载体 Ad-CEA-CD，分别转染 CEA 阳性
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                      材料和方法 
1.主要材料 
1.1 质粒和菌株 
     载体 PcDNA3.1(-)购自 Novagen 公司。大肠杆菌 ToP10 菌株由厦门大学医学院抗
癌中心提供。 
1.2 细胞株和实验动物 
     1.人大肠癌细胞株 SW480 购自上海中国科学院细胞库。 
2.Hela 细胞株由厦门大学医学院抗癌中心提供。 
3.正常人血由厦门大学附属中山医院提供。 
4.SPF BALB/C 裸小鼠，4-6 周龄，雌性，体重 18-20g，购自中国科学院上海实验
动物中心。 
1.3 主要仪器设备 
Biofuge stratos 冷冻高速离心机             Heraeus 
TGL-16G 台式离心机                     上海安亭科学仪器厂 
PYX-DHS 隔水式电热恒温培养箱          上海医疗器械七厂 
DYCP-31C 型电泳槽                     北京市六一仪器厂 
手提式压力蒸汽灭菌器                   上海博迅实业有限公司医疗设备厂 
GEL DXR 凝胶成像系统                  Bio-Rad 
天能 UV-2000 紫外分析仪                天能（上海）科技有限公司 
HF16 二氧化碳培养箱                    Heal Force Development Co.Ltd 
PTC-100TMPCR 仪                       MJRESEARCH.INC 
超净工作台                             上海博讯公司 
BD375 冰柜                             海尔公司 
AL204 电子天平                         Mettler-Toledo 
AE31/CCIS LWD 倒置显微镜              MOLTIC Co.Ltd 
ULT-1386-V37/379L 超低温冰箱           Asheville NC USA 
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游标卡尺                              上海精密仪器设备厂 
1.4 主要试剂 
     RPMI1640 培养基                      Gibco 公司 
     DMEM medium                        Gibco 公司 
     LB medium                           上海生工公司 
     Cycle-Pure kit                          Omega bio-tek 
     Plasmid Miniprep kitⅠ                  Omega bio-tek 
     Gel extraction kit                       Omega bio-tek 
     细胞基因组 DNA 提取试剂盒            北京博大泰克 
     Pfu DNA 聚合酶及其反应体系           北京天根公司 
     Taq DNA 聚合酶及其反应体系           上海生工公司 
     新生小牛血清                         杭州四季青公司 
     胰蛋白酶                             上海生工公司 
     限制性内切酶及其反应体系              NEB 公司 
     T4 DNA 连接酶及其反应体系            NEB 公司 
     EB                                   上海生工公司 
     丙氧鸟苷                              Sigma 公司 
     5-氟胞嘧啶                            Fluka 公司 
     阳离子脂质体（Lipofectamine）          Invitrogen 公司 
     RT-PCR 试剂盒                        上海生工公司 
     Trizol 试剂盒                          上海生工公司 
     琼脂糖                               上海华美公司 
     胰蛋白酶                             上海华美公司 
     实验用水为三蒸水                      自制 
     DNA marker、Protein marker             上海生工公司 
     氨苄青霉素                           上海生工公司 
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